Therapy for intrauterine growth restriction: current options and future directions.
Pollack
R N
RN
Bikur Cholim Hospital, Jerusalem, Israel.
Yaffe
H
H
Divon
M Y
MY
D000318:Adrenergic beta-Agonists / Q000627:therapeutic use; D001241:Aspirin / Q000627:therapeutic use; D009320:Atrial Natriuretic Factor / Q000627:therapeutic use; D001510:Bed Rest; D016861:Cyclooxygenase Inhibitors / Q000627:therapeutic use; D004176:Dipyridamole / Q000627:therapeutic use; D005260:Female; D005317:Fetal Growth Retardation / Q000503:physiopathology / Q000517:prevention & control / Q000628:therapy*; D006801:Humans; D008429:Maternal Welfare; D009747:Nutritional Physiological Phenomena; D010102:Oxygen Inhalation Therapy; D011247:Pregnancy; D013002:Somatomedins / Q000032:analysis; D014665:Vasodilator Agents / Q000627:therapeutic use
D000318:Adrenergic beta-Agonists; D016861:Cyclooxygenase Inhibitors; D013002:Somatomedins; D014665:Vasodilator Agents; D004176:Dipyridamole; D009320:Atrial Natriuretic Factor; D001241:Aspirin